AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas
Publication
, Conference
Khasraw, M; Hofman, MS; Chantrill, L; Pavlakis, N; Gebski, V; Gill, AJ; Markman, B; Yip, S; Gibbs, E; Karapetis, C; Wong, SF; Ransom, DT ...
Published in: ANNALS OF ONCOLOGY
September 1, 2017
Duke Scholars
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
September 1, 2017
Volume
28
Location
Madrid, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
42nd European-Society-for-Medical-Oncology Congress (ESMO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Khasraw, M., Hofman, M. S., Chantrill, L., Pavlakis, N., Gebski, V., Gill, A. J., … Lipton, L. (2017). AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas. In ANNALS OF ONCOLOGY (Vol. 28). Madrid, SPAIN: OXFORD UNIV PRESS.
Khasraw, M., M. S. Hofman, L. Chantrill, N. Pavlakis, V. Gebski, A. J. Gill, B. Markman, et al. “AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas.” In ANNALS OF ONCOLOGY, Vol. 28. OXFORD UNIV PRESS, 2017.
Khasraw M, Hofman MS, Chantrill L, Pavlakis N, Gebski V, Gill AJ, et al. AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2017.
Khasraw, M., et al. “AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas.” ANNALS OF ONCOLOGY, vol. 28, OXFORD UNIV PRESS, 2017.
Khasraw M, Hofman MS, Chantrill L, Pavlakis N, Gebski V, Gill AJ, Markman B, Yip S, Gibbs E, Karapetis C, Wong SF, Ransom DT, Michael M, Wilson K, Simes J, Lipton L. AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2017.
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
September 1, 2017
Volume
28
Location
Madrid, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
42nd European-Society-for-Medical-Oncology Congress (ESMO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis